1.03
-0.03 (-2.83%)
-0.03 (-2.83%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AIM ImmunoTech Inc | AIM | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -2.83% | 1.03 | 1.02 | 1.0499 | 1.03 | 1.06 | 12:06:48 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,239 | 812,396 | $ 1.03 | $ 835,200 | 4,667,982 | 0.381 - 3.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:06:48 | 1,000 | $ 1.03 | USD |
AIM ImmunoTech Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 8.44M | 8.26M | $ 2.52M | -9.56 | - | 5.17M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 699.13k | $ - | 0.00% | - | - |
AIM ImmunoTech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.25 | 1.00 | 1.06 | 2,162,162 | -0.12 | -10.43% |
| 1 Month | 1.13 | 1.74 | 0.78 | 1.14 | 5,691,130 | -0.10 | -8.85% |
| 3 Months | 0.45 | 1.74 | 0.3877 | 1.04 | 2,864,746 | 0.58 | 128.89% |
| 6 Months | 1.96 | 3.88 | 0.381 | 1.06 | 1,679,193 | -0.93 | -47.45% |
| 1 Year | 1.96 | 3.88 | 0.381 | 1.06 | 1,679,193 | -0.93 | -47.45% |
| 3 Years | 1.96 | 3.88 | 0.381 | 1.06 | 1,679,193 | -0.93 | -47.45% |
| 5 Years | 1.96 | 3.88 | 0.381 | 1.06 | 1,679,193 | -0.93 | -47.45% |
AIM ImmunoTech Description
| AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States. |
